Amarin Corp Plcuk (AMRN) Other Gross PP&E Adjustments (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Other Gross PP&E Adjustments of -$6.0 million for Q1 2026, up 28.45% year-over-year from -$4.7 million in Q1 2025, and down 19.86% quarter-over-quarter from -$5.0 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Gross PP&E Adjustments (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Other Gross PP&E Adjustments data on file, last reported at -$6.0 million in Q1 2026.

  • Other Gross PP&E Adjustments for Q1 2026 came in at -$6.0 million, up 28.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.0 million (up 28.45% YoY), and the FY2025 annual result was -$5.0 million, up 17.99% from the prior year.
  • Other Gross PP&E Adjustments retreated to -$6.0 million in Q1 2026 per AMRN's latest filing, from -$5.0 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$5.0 million in Q4 2025 and troughed at -$9.2 million in Q1 2023.
  • A 5-year average of -$7.6 million and a median of -$7.9 million in 2024 frame the typical range for Other Gross PP&E Adjustments.
  • The sharpest annual moves came in 2022 and 2026: Other Gross PP&E Adjustments slumped 33.38% in 2022, then climbed 28.45% in 2026.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$5.8 million in 2022, then retreated by 18.47% to -$6.8 million in 2023, then rose by 10.31% to -$6.1 million in 2024, then gained by 17.99% to -$5.0 million in 2025, then decreased by 19.86% to -$6.0 million in 2026.
  • Business Quant data shows AMRN's Other Gross PP&E Adjustments at -$6.0 million in Q1 2026, -$5.0 million in Q4 2025, and -$7.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -941.03 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 49.60 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -2.70 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 8.42 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -1.53 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -6.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.01 Mn
Mar 31, 2026 -6.01 Mn
Dec 31, 2025 -5.01 Mn
Dec 31, 2025 -5.01 Mn
Sep 30, 2025 -7.20 Mn
Sep 30, 2025 -7.20 Mn
Jun 30, 2025 -7.64 Mn
Jun 30, 2025 -7.64 Mn
Mar 31, 2025 -8.40 Mn
Mar 31, 2025 -8.40 Mn
Dec 31, 2024 -6.11 Mn
Dec 31, 2024 -6.11 Mn
Sep 30, 2024 -7.98 Mn
Sep 30, 2024 -7.98 Mn
Jun 30, 2024 -7.54 Mn
Jun 30, 2024 -7.54 Mn
Mar 31, 2024 -7.90 Mn
Mar 31, 2024 -7.90 Mn
Dec 31, 2023 -6.82 Mn
Dec 31, 2023 -6.82 Mn